Alemtuzumab
Drug timelines are a Plus or Pro feature.
90 regulatory and trial events tracked for Alemtuzumab, covering 2009-06-22 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide [EARLY_Phase 1]